Dr. Jeffrey Bruce: "This new approach has the potential to transform treatment for patients with brain cancer, where the outlook for survival remains very poor."
Sharon Howell had an encouraging response as a patient in the I-SPY clinical trials, and the outcome could also translate to a lower likelihood of her cancer coming back in the future.
The new $10 million Columbia-Pfizer Clinical Trials Diversity Initiative will aim to reduce health disparities by increasing the participation of underrepresented minorities in clinical trials.
New clinical trial studies the application of focused ultrasound technique to deliver chemotherapy in patients with DIPG, an aggressive type of brain cancer.
Results of a new phase 2 clinical trial demonstrate the potential of targeted therapy in combination with chemotherapy to treat patients with uterine leiomyosarcoma.
November marks Pancreatic Cancer Awareness month, and in this in-depth Q+A, Dr. Gulam Manji takes us through the exciting advances in pancreatic cancer treatment and research.